BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death

搜尋結果

• 2022

  BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death

  Ko, H. J., Chiou, S. J., Tsai, C. Y., Loh, J. K., Lin, X. Y., Tran, T. H., Hou, C. C., Cheng, T. S., Lai, J. M., Chang, P. M. H., Wang, F. S., Su, C. L., Huang, C. Y. F. & Hong, Y. R., 2022 12月, 於: Cell Communication and Signaling. 20, 1, 200.

  研究成果: 雜誌貢獻 › 期刊論文 › 同行評審

  開啟存取

  • cancer 100%
  • therapy 100%
  • apoptosis 100%
  • biological markers 50%
  • inhibition 50%

  13   !!Link opens in a new tab 引文 斯高帕斯（Scopus）